Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.74, $0.05 better than the analyst estimate of $0.69. Revenue for the quarter came in at $170.5 million versus the consensus estimate of $174.35 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.